Combined effect of Saraswatha Churna internally and Thungadrumadi Taila externally on head in managing mild anxiety and depressive disorders

A clinical trial to evaluate the combined efficacy of Saraswatha churna and Thungadrumadi taila in managing mixed depressive and anxiety disorder - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070240

Enrollment

Registered

2024-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F41- Other anxiety disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of age 18 – 40 years. 2.Subjects irrespective of gender and socio-economic status. 3.Subjects fulfilling ICD-11 criteria for Mixed Depressive and Anxiety Disorders.

Exclusion criteria

Exclusion criteria: 1.Subjects scoring more than 17 in HAM-A. 2.Subjects scoring more than 20 IN HDRS. 3.Subjects taking medication for Depression/Anxiety/ other Psychiatric disorders. 4.Subjects who are known allergic to any of the ingredients. 5.Pregnant and lactating women. 6.Subjects with substance abuse. 7.Subjects with uncontrolled systemic disorders. 8.Subjects with violent behavior and self-harming actions and/or has suicidal ideations.

Design outcomes

Primary

Measure	Time frame
1.To evaluate the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in managing mixed depressive and anxiety disorder 2.To determine the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in improving the emotional intelligence of an individual using SSEIT questionnaire 3.To determine the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in improving the quality of life in an individual using WHOQOL questionnaire Timepoint: Clinical assessment of symptoms of MDAD as per ICD-11 criteria, HAM-A, HDRS on 0th day, 16th day, 31st day and on 46th day Serum cortisol at 8 am on 1st day and 31st day Assessment of emotional intelligence using SSEIT score on 0th day and 46th day Assessment of the quality of life in an individual using WHOQOL score on 0th day and 46th day	—

Measure

Time frame

1.To evaluate the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in managing mixed depressive and anxiety disorder 2.To determine the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in improving the emotional intelligence of an individual using SSEIT questionnaire 3.To determine the combined efficacy of Saraswatha Churna and Thungadrumadi Taila in improving the quality of life in an individual using WHOQOL questionnaire Timepoint: Clinical assessment of symptoms of MDAD as per ICD-11 criteria, HAM-A, HDRS on 0th day, 16th day, 31st day and on 46th day Serum cortisol at 8 am on 1st day and 31st day Assessment of emotional intelligence using SSEIT score on 0th day and 46th day Assessment of the quality of life in an individual using WHOQOL score on 0th day and 46th day

—

Secondary

Measure	Time frame
To evaluate the safety of Saraswatha churna in subjects with Mixed Depressive and Anxiety DisorderTimepoint: Blood Routine Examination with Erythrocyte Sedimentation Rate, Liver Function Test, Renal Function Test will be done on 0th day and 31st day	—

Countries

India

Contacts

Public ContactJayalakshmi Venugopal

Pankajakasthuri Ayurveda Medical College and Post Graduate Centre

venusha.jaya@gmail.com8943293929

Outcome results